Business Investment Opportunities

The business is located in Kolhapur and operates as a hybrid multispecialty pharma wellness clinic, offering branded generic medicines, health ATM services, and consultations. - The company has 6 employees and has been operational from 3 years, with plans to expand its service offerings in the near future. - Existing client base 25 k Plus- which optimize near about 200-300 customers through walking on daily basis. - Current Daily revenue genrate around 50 K. - Started the business with a lot of R&D and opened one clinic and pharmacy. Now we are set to launch more branches. - The business model has demonstrated strong revenue generation and is positioned to benefit from the enduring demand in the market. Revenue mentioned is from the running clinic and pharmacy. - All the details will be provided in Excel sheets as well as project reports for the interested investor.

Currently supplying to 2,200 retailers. We only supply the products to clients in Mumbai and Raigad. - Around 15 vendors supply the products to us. - The minimum order value for clients outside the state is INR 1 lakh. - We possess GST, USFDA, and Food licenses. These are the major licenses and certificates required to run this business. - Promoter has 8 years of experience in this industry.

Updates on the business: The facility will have growing/extraction/distillation/packaging and R&D lab facilities in order to follow the entire stage of production from mother plants to crystallized forms of stand-alone cannabinoids. The intended R&D lab will be almost 200 sq. m. and will allow us to study lesser-known cannabinoids, and after the start of construction, we are going to sign the 'Partnership Joint Research' program with Athens University. Currently have signed a partnership agreement with a running pharmaceutical company on product supply + joint research program. Later on, we will focus on the distribution channels in each country of presence in order to be prepared to scale to the B2C market with potential own generic medicine and potentially edibles, but that will be decided by the market needs and legislation. We have received an installation license for such end products and as the project progresses we will add new products to the list: - Dried hemp flower > 0.2% THC in the form of teabag (tea bag) for oral consumption; - Hemp oil in drops for oral consumption > 0.2% THC; - Hemp oil for sublingual oral consumption (spray) > 0.2% THC; - Soft cannabis capsules for oral consumption > 0.2% THC; - Capsules with dried hemp blossom > 0.2% THC in powder form for oral consumption. At the moment we have: License and permits; Architectural and engineering plans; Purchase offers from equipment suppliers; All described production processes and laboratories; Long-term land lease for 30+ years with first an option of first to purchase it; Long-term lease and right of build on the neighboring land for the second stage of construction; The entire legal structure of the holding; Verification of processes and architectural solutions under EU GACP & EU GMP standards. By the end of last year have applied for the state subsidy of EUR 3.5mil and have the option to apply for the second state subsidy next year. Additionally, the project has a right for setting fixed corporate tax for the next 12 years. Overall the production facility is projected to grow 6.5+ tons of dried biomaterial (running at 70% capacity) on a single-tier growing table with the ability of scale and potential purchase of third-party biomaterial certified by GACP standards. The EU GMP Laboratory is projected to produce 2+ tons of fine oil with an option of scaling by putting a second processing line. Additionally, the project is built in mind with an option for a second-stage expansion through the building of an additional production site on the neighboring land.

Engaged in pharmaceutical manufacturing, supplying tablets and capsules to both domestic and international markets. - Operates from an 18,000 sq. ft. constructed manufacturing facility located in Gujarat. - The facility supports a monthly production of approximately 4 crore tablets/capsules. - Holds a valid drug license and GST registration, Exim license, ensuring regulatory compliance for manufacturing and distribution. - Business model centers on contract manufacturing and long-term partnerships with pharma companies. - Team includes experienced professionals with technical and regulatory expertise in pharma manufacturing and export compliance.

• Operating from Cebu City, this pharmaceutical distribution business is strategically seeking product partnerships and investors. • With a dynamic portfolio of 9 SKUs, and 2 additional high-demand products arriving next week, the business offers a lucrative opportunity for stakeholders in the pharmaceutical supply chain. • The firm holds an FDA permit for its entire product range, ensuring compliance with regulatory standards and enhancing trust among distributors and retailers. • The generic products, procured from established exporters in India and China, are rebranded as proprietary before distribution, optimizing brand value and market recognition. • Having secured substantial inventory in September and October of the previous year, the business is ready for distribution. • The company operates with minimal operational overheads, maximizing profitability and offering attractive returns for potential investors.

Distributors for pharmaceutical companies. - Top-selling human albumin and retina products. - Supply to hospitals, government, and corporate customers like ASG and Sharp Sight. - Major revenue from hospitals in Varanasi and peripheral areas. - 14 years of experience in the retina and plasma-derived products like albumin, IVIG, HBIG, and HRIG. - The drug is used in treating ICU and kidney patients. - Promoters have 20 years of experience in the industry. - Purchase goods at cost from pharmaceutical companies. - Exclusive territorial rights in Varanasi for selling goods. - Partnerships with 60 hospitals and clinics. - Licensed with GST, drug, and FSSAI certifications. - Since we are highly efficient in our operations, we have a low employee count and a lean business model.